[Methylobacterium radiotolerans bacteremia in hemodialysis patients].
Central venous catheters (CVCs) play an important role in replacement therapy for patients with acute and chronic renal failure. Secondary infections due to central venous access are responsible for 48-73% of bacteremia in hemodialysis patients and are an important cause of morbidity and increased health costs for these patients. Episodes of unexplained fever were noted in hemodialysis patients in our center starting in October 2006. An investigation for causative microorganisms was conducted from October 2006 to April 2007. Bacterial DNA was extracted and amplified using universal primers for bacterial 16S. Amplification by multiple PCR was performed on the samples and the subsequent sequencing led to the identification of the microorganism of interest as belonging to Methylobacterium radiotolerans. We report the largest cluster of dialysis catheter-related bloodstream infections caused by M. radiotolerans, and describe the difficulties in the prompt and correct identification of these bacteria. Thirty-seven patients had positive cultures for M. radiotolerans from blood (2.7%) or CVC (29.7%) or both (67.6%). After removal and replacement of CVCs and antibiotic therapy and the strict application of an infection management protocol, there were no more fever episodes or cultures positive for M. radiotolerans.
de Cal
M
M
Dipartimento di Nefrologia, Dialisi e Trapianto, Ospedale San Bortolo, Vicenza, Italy. mamo00@libero.it
Cazzavillan
S
S
Cruz
D
D
Nalesso
F
F
Brendolan
A
A
Rassu
M
M
Ronco
C
C
D058186:Acute Kidney Injury / Q000628:therapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000453:epidemiology / Q000382:microbiology*; D055499:Catheter-Related Infections; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling; D003428:Cross Infection; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D020580:Methylobacterium / Q000302:isolation & purification*; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012189:Retrospective Studies
D000900:Anti-Bacterial Agents